Alzheimer's disease pathophysiology: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
==Pathogenesis== | ==Pathogenesis== | ||
Alzheimer disease (AD), is a progressive neurodegenerative disorder. The dysfunction of amyloid precursor protien (APP) metabolism and the resulting build up of of Aβ peptides and their aggregation in the form of senile plaques in the brain parenchyma of individuals have been considered pivotal for neurodegeneration in the disease. There is also an accumulation of intracellular neurofibrillary tangles that consist of hyperphosphorylated tau protein and a profound loss of basal forebrain cholinergic neurons that innervate the hippocampus, and the neocortex. | |||
== Triggers == | |||
The following factors lead to the development of Alzheimer's dementia: | |||
* Genetic factors | |||
* Environmental factors | |||
=== Genetic Factors === | |||
Genetic origin of Alzheimer's dementia (AD) demonstrates an autosomal dominant pattern of inheritance. Alzheimer's dementia arising from genetic alterations may lead to early onset (<60 years) of disease. The following mutations are implicated in the development of AD are: | |||
==== Early onset (Alzheimer's dementia-AD 1, 3 and 4) ==== | |||
30-50 percent of early-onset Alzheimer's dementia (AD) is associated with an autosomal dominant inheritance and consists of mutations in the following genes: | |||
* Presenilin1 (''PS1'') gene, also called PSEN1 gene on chromosome 14 (AD3- 20 to 30 percent cases) | |||
* Presenilin 2 (''PS2'') gene, also called PSEN2 gene on chromosome 1 (AD4- rare) | |||
* Point mutations in amyloid beta A4 protein gene, also called amyloid precursor protein (APP) gene on chromosome 21 are associated in some cases of early onset (< 65 yr) familial AD cases | |||
'''Late onset (Alzheimer's dementia -AD2)''' | |||
* Apolipoprotein 4 gene (APOE4) mutation is associated with late onset (>60 years) Alzheimer's dementia (AD) | |||
=== Hypotheses for Alzheimer's dementia === | |||
Two major hypothese for the development of Alzheimer's dementia (AD) have been proposed: | |||
'''Amyloid cascade hypothesis'''<div style="-webkit-user-select: none;"> | |||
Revision as of 17:34, 17 September 2017
| https://https://www.youtube.com/watch?v=v5gdH_Hydes%7C350}} |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Alzheimer's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Alzheimer's disease pathophysiology On the Web |
|
American Roentgen Ray Society Images of Alzheimer's disease pathophysiology |
|
Risk calculators and risk factors for Alzheimer's disease pathophysiology |
Overview
Pathogenesis
Alzheimer disease (AD), is a progressive neurodegenerative disorder. The dysfunction of amyloid precursor protien (APP) metabolism and the resulting build up of of Aβ peptides and their aggregation in the form of senile plaques in the brain parenchyma of individuals have been considered pivotal for neurodegeneration in the disease. There is also an accumulation of intracellular neurofibrillary tangles that consist of hyperphosphorylated tau protein and a profound loss of basal forebrain cholinergic neurons that innervate the hippocampus, and the neocortex.
Triggers
The following factors lead to the development of Alzheimer's dementia:
- Genetic factors
- Environmental factors
Genetic Factors
Genetic origin of Alzheimer's dementia (AD) demonstrates an autosomal dominant pattern of inheritance. Alzheimer's dementia arising from genetic alterations may lead to early onset (<60 years) of disease. The following mutations are implicated in the development of AD are:
Early onset (Alzheimer's dementia-AD 1, 3 and 4)
30-50 percent of early-onset Alzheimer's dementia (AD) is associated with an autosomal dominant inheritance and consists of mutations in the following genes:
- Presenilin1 (PS1) gene, also called PSEN1 gene on chromosome 14 (AD3- 20 to 30 percent cases)
- Presenilin 2 (PS2) gene, also called PSEN2 gene on chromosome 1 (AD4- rare)
- Point mutations in amyloid beta A4 protein gene, also called amyloid precursor protein (APP) gene on chromosome 21 are associated in some cases of early onset (< 65 yr) familial AD cases
Late onset (Alzheimer's dementia -AD2)
- Apolipoprotein 4 gene (APOE4) mutation is associated with late onset (>60 years) Alzheimer's dementia (AD)
Hypotheses for Alzheimer's dementia
Two major hypothese for the development of Alzheimer's dementia (AD) have been proposed:
Amyloid cascade hypothesis